Neuropsychiatric Drug Development Summit on September 24-26, 2024 in Boston, United States
- Event Type: Conference
- Presentation: Physical
- Website URL: http://go.evvnt.com/2433814-0?pid=10008
- Contact E-mail: [email protected]
- Location: Boston, United States
- Venue: Hilton Boston Back Bay
- Date: September 24-26, 2024
- Organization: Hanson Wade Group
- Conference Tags: health health science public health healthcare health systems
With Karuna's schizophrenia program coined as the most anticipated drug launch of 2024, and 2023 bringing brand new regulatory guidance, surging investment has reinvigorated the space with new targets, mechanisms, and technologies to transform the mental health treatment landscape.
Capitalizing on a new wave of pipeline momentum, the 7th Neuropsychiatric Drug Development Summit returns as the industry's premier gathering, showcasing the latest circuit-based target innovation, EEG and digital biomarker data, in vivo and in vitro model advances, pioneering precision psychiatry approaches and more.
Join discovery, preclinical, translational, clinical, regulatory, and commercial experts from Karuna, Janssen, AbbVie, Otsuka, Sage Therapeutics, Lykos, Lundbeck, Compass, Biogen, Delix Therapeutics, and more as they address biopharma's most pressing challenges in a collaborative atmosphere to accelerate the race to approval for transformative neuropsychiatric candidates.
URLs:
Tickets: https://go.evvnt.com/2433814-2?pid=10008
Brochure: https://go.evvnt.com/2433814-3?pid=10008
Time: 8:00 AM - 5:00 PM
Prices:
Drug Developer Pricing - Conference + Workshop Day: USD 3597.00,
Drug Developer Pricing - Conference Only: USD 2599.00,
Solution Provider Pricing - Conference + Workshop Day: USD 5197.00,
Solution Provider Pricing - Conference Only: USD 3699.00
Speakers: Aaron Koenig, Chief Medical Officer, Delix Therapeutics, Ariana Mullin, Director, Regulatory Affairs, Bristol Myers Squibb, Ayan Ghoshal, Head of Neural Circuits, Associate Director, Biogen, Berra Yazar-Klosinski, Chief Scientific Officer, Lykos Therapeutics, Charmaine Lykins, Chief Commercial Officer, MapLight Therapeutics, Cornelia Dorner-Ciossek, Head of Digital Health TA CNS Retinopathies Emerging Areas, Boehringer Ingelheim, Dalibor Sames, Co-Founder, Gilgamesh Pharmaceuticals and Faculty, Columbia University, Daniel Karlin, Chief Medical Officer, Mind Medicine Inc., Daniel Smith, Executive Director and Head of Translational Medicine, Alkermes, Dina Burkitbayeva, Chief Executive Officer, Freedom Biosciences, Elemer Piros, Senior Managing Director, Rodman and Renshaw, Estibaliz Arce Cirauqui, Vice President - Translational Science and Clinical Development, Engrail Therapeutics, George Papakostas, Associate Executive Director, Clinical Trials Network and Institute, Massachusetts General Hospital, Gregory Ryslik, Chief Technology Officer, COMPASS Pathways, Guy Goodwin, Chief Medical Officer, COMPASS Pathways, Harald Murck, Apl. Professor, Philipps-Universität Marburg, Jackie von Salm, Co-Founder and Chief Scientific Officer, Psilera Bioscience, Jeffrey Brown, Chief Scientific Officer, Sensorium Therapeutics, Kevin Sanders, Executive Medical Director- CNS, Otsuka, Kjartan Frisch Herrik, Research Fellow, Lundbeck, Kurt Rasmussen, Chief Scientific Officer, Delix Therapeutics, Matt Kuntz, Vice President, Global Regulatory Strategy, Neuroscience, Abbvie, Matthew Harlin, Senior Director, CNS Discovery Research, Early Phase and Translational Medicine, Otsuka, Matthew Johnson, Senior Group Leader, The Broad Institute of MIT and Harvard, Michael McCully, Co-Founder, Gate Neurosciences, Inc., Michele Hummel Director, Early Phase Development and Translational Medicine, Otsuka, Moeen Panni, Head of Neuropsychiatry, Medical Affairs, Biogen, Nina Dedic, Senior Director, Head of CNS Pharmacology, Discovery Sciences, Sumitomo Pharma Oncology, Patricio O’Donnell, Vice President and Head of Translational Medicine, SAGE Therapeutics, Paul Imm, Senior Director, Global Regulatory Affairs - Neuropsychiatry, Janssen, Robert Discordia, Chief Executive Officer, Equulus Thrapeutics, Shaheen Lakhan, Chief Medical Officer, Click Therapeutics, Snezana Milanovic, Senior Director, TMED and Early Development, Sumitomo Pharma America Holdings, Inc., Stephen Brannan, Former Chief Medical Officer, Karuna Therapeutics, Steve Kanes, Chief Executive Officer, EmbarkNeuo, Umed Boltaev, Associate Research Scientist, Columbia University, Wayne Drevets, Vice President, Disease Area Team Leader, Neuroscience, Janssen, Zoë Hughes, Vice President, Head of Biology, Gilgamesh Pharmaceutical
Name: Hanson Wade Group
Address: 52 Grosvenor Gardens
- August 05, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Vancouver, Canada
- November 18, 2024 International Conference on Medical and Health Sciences (ICMHS) - Singapore, Singapore
- August 08, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Baku, Azerbaijan
- December 16, 2024 International Conference on Medical and Health Sciences (ICMHS) - Vientiane, Laos
- October 17, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Istanbul, Turkey
- July 18, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Paris, France
- December 30, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Karachi, Pakistan
- September 26, 2024 International Conference on Medical and Health Sciences (ICMHS) - San Francisco, United States
- October 24, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Barcelona, Spain
- December 09, 2024 International Conference on Medicine, Health Care and Philosophy (ICMHCP) - Kuala Lumpur, Malaysia
- September 05, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Prague, Czechia
- November 07, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Dubai, United Arab Emirates
- October 17, 2024 International Conference on Neurology and Epidemiology (ICNE) - Kathmandu, Nepal
- August 15, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Tokyo, Japan
- September 16, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Santiago, Chile
- October 28, 2024 International Conference on Medical and Health Sciences (ICMHS) - Lisbon, Portugal
- August 15, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Venice, Italy
- December 16, 2024 International Conference on Neurology and Epidemiology (ICNE) - Vientiane, Laos
- December 02, 2024 International Conference on Neurology and Epidemiology (ICNE) - Auckland, New Zealand
- December 02, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Sydney, Australia
- September 16, 2024 International Conference on Neurology and Epidemiology (ICNE) - Paris, France
- December 30, 2024 International Conference on Medical and Health Sciences (ICMHS) - Paris, France
- August 22, 2024 International Conference on Medical and Health Sciences (ICMHS) - Budapest, Hungary
- July 22, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Rome, Italy
- November 11, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Venice, Italy
- October 17, 2024 International Conference on Medical and Health Sciences (ICMHS) - London, United Kingdom
- October 28, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Los Angeles, United States
- September 19, 2024 International Conference on Medicine and Health Sciences (ICMHS) - London, United Kingdom
- October 03, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Dubrovnik, Croatia
- August 05, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Montreal, Canada
- November 18, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Reykjavik, Iceland
- November 11, 2024 International Conference on Medical and Health Sciences (ICMHS) - Jeddah, Saudi Arabia
- August 08, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Warsaw, Poland
- July 22, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Rome, Italy
- December 02, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Sydney, Australia
- August 15, 2024 International Conference on Health Informatics and Health Information Management (ICHIHIM) - Istanbul, Turkey
- August 29, 2024 International Conference on Medicine and Health Sciences (ICMHS) - Zanzibar, Tanzania
- September 26, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - San Francisco, United States
- October 28, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Osaka, Japan
- August 15, 2024 International Conference on Neurology and Epidemiology (ICNE) - Bangkok, Thailand
- August 22, 2024 International Conference on Gender, Sex and Healthcare (ICGSH) - Budapest, Hungary
- August 22, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - Rome, Italy
- August 29, 2024 International Conference on Alternative Healthcare and Acupuncture (ICAHA) - Moscow, Russia
- November 04, 2024 International Conference on Pulmonary and Respiratory Medicine (ICPRM) - San Francisco, United States
- November 04, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Nicosia, Cyprus
- October 17, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - London, United Kingdom
- August 15, 2024 International Conference on Preventive Medicine and Integrative Medicine (ICPMIM) - Venice, Italy
- November 25, 2024 International Conference on Medical and Health Sciences (ICMHS) - London, United Kingdom
- July 29, 2024 International Conference on Nuclear Medicine and Biology (ICNMB) - Zurich, Switzerland
- November 07, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - New York, United States
- September 11, 2024 Pre Filled Syringes Connect - Boston, United States
- July 09, 2024 Advancing Ocean CDR Summit - Boston, United States
- July 09, 2024 In Vivo Cell Engineering and Gene Editing Summit - Boston, United States
- July 10, 2024 Microbiome Movement Drug Development Summit - Boston, United States
- July 16, 2024 Gene Therapy Potency Assay Summit - Boston, United States
- July 23, 2024 Women's Health Therapeutics And Diagnostics Summit - Boston, United States
- July 23, 2024 ADC Toxicity Summit - Boston, United States
- July 23, 2024 Tumor Models - Boston, United States
- July 23, 2024 Induced Proximity-Based Drug Discovery Summit - Boston, United States
- July 29, 2024 mRNA-Based Therapeutics Summit - Boston, United States